Current treatment status and prospect of triple-negative breast cancer

VernacularTitle: 三阴性乳腺癌的治疗现状及进展
Author: Jie ZHOU ¹ ; Xuan CHEN ² ; Yu CHEN ¹ ; Dao-zhen CHEN ¹
Author Information

1. Department of Central Laboratory, Wuxi Hospital for Maternal and Child Health Care Affiliated to Nanjing Medical University, Wuxi 214002, Jiangsu, China
2. Kangda College of Nanjing Medical University, Lianyungang 222023, Jiangsu, China
Publication Type:Journal Article
Keywords: triple-negative breast cancer; chemotherapy; targeted therapy; immunotherapy; endocrine therapy
From: Journal of Medical Postgraduates 2018;31(8):853-858
CountryChina
Language:Chinese
Abstract: Breast cancer is one of the most common female malignancies in China. The morbidity and mortality rate of breast cancer is rising. Triple-negative breast cancer (TNBC) is a heterogeneous disease, characterized with younger, more aggressive and easier recurrence or metastasis. Because there is no standard therapeutic regimen, TNBC has poor efficacy and prognosis, and seriously affects the patients′ health. Summarizing and combing the status and progress of TNBC treatment can help us to better understand the disease and improve treatment. In addition, it inspires us to form new research ideas and explore the research directions of TNBC.